Diabetes Treatments | Novo Nordisk U.S.
View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.
Our medicines | Diabetes medications | Obesity medication - Novo Nordisk
Overview of our diabetes medications, obesity medication and also medicines within haemophilia, human growth hormone and hormone replacement therapy.
Our products - Novo Nordisk
Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page. Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Diabetes Treatments & Insulin Pen Devices | NovoCare®
Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.
Our products | Novo Nordisk U.S.
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
Novo Nordisk Product Library | Scientific Exchange
Access information and resources on Novo Nordisk products available to treat Diabetes, Obesity, Growth Hormone Disorders, Hemophilia & Rare Bleeding Disorders.
Check out our comprehensive chart to understand how your meds work, and keep the list handy for times when your health care provider suggests changes to your treatment plan. Helps insulin work better in muscle and fat cells. Lowers glucose production in the liver. Blocks glucose from being reabsorbed by the kidneys.
Diabetes Treatment Information for Health Care Professionals - novoMEDLINK
Review information for Novo Nordisk's comprehensive diabetes treatment portfolio, with Pharmacy Reference Guides for quick access to dosing and storage information.
Treatment Options for Type 2 Diabetes - NovoCare
There are many medication options for treating type 2 diabetes. Learn the differences between GLP-1 RA, insulin, non-insulin, oral anti-diabetic drugs, and more.
Follow-on medications are “copies” of brand-name drugs already on the market. Insulin Aspart FOB and Insulin Aspart Mix 70/30 FOB are follow-on brand versions of NovoLog and Novolog Mix 70/30.
- Some results have been removed